Policy support to the county tilt, the grass-roots market is about to usher in a big outbreak

"Pharmaceutical Network Market Analysis" Recently, about Baiji Shenzhou, AstraZenew and other foreign pharmaceutical companies to form county team news, you can see more and more pharmaceutical companies are moving towards the grass-roots level.
3% in 2019, compared with 5.1% in county-level public hospitals, according to the company's data.
can be said that in terms of drug market growth, the county-level public hospital market has great potential.
generally believed that in the future, with the promotion of graded diagnosis and treatment, county medical and health community construction and other policies, the pharmaceutical market will also sink to the county area, the county grass-roots market will usher in a major outbreak.
In May 2019, the National Health and Wellness Commission issued the Notice on the Pilot Work of the Construction of the Urban Medical Complex and the Notice on Promoting the Construction of the Close County Medical and Health Community, which clearly mentions that by the end of 2020, the county level will reach 90%, the county primary level consultation rate will reach about 65%, and the number of technologies and projects that primary health care institutions have the ability to carry out will continue to increase.
, the circular also stressed that the county medical system should focus on strengthening the health management of patients with hypertension, diabetes, severe mental disorders, tuberculosis and so on.
In June 2019, the National Health and Health Commission issued the Notice on the Issue of the List of County Hospitals in the Second Phase of comprehensively Improving the Comprehensive Capacity of County Hospitals, which identified 500 county-level hospitals and 500 county-level Chinese medicine hospitals in the second phase of comprehensively upgrading the comprehensive capacity of county-level hospitals, which have the opportunity to be upgraded to triple-A hospitals.
it is not difficult to see that the document clearly tilts the focus of support towards primary health care.
, the "Notice on the issuance of a close county medical and health community construction evaluation standards and monitoring indicators system (trial)" was officially issued, which means that the development of the county medical community has entered a substantive promotion stage.
a series of policies, we can see that the county grass-roots market is becoming more and more important.
its development has also attracted the attention of the industry.
, however, in the industry's view, the development of the Community will also face certain challenges.
with the deepening of the reform of the payer, the appraisal system will focus on the quality of medical care, the coordination between the medical service system will become the main direction of development.
, the advantages of the current county-level hospitals are mainly reflected in outpatient absorption and routine hospitalization.
in recent years, the overall development of county hospitals has also been relatively fast, becoming the second only to the third-level hospital plate.
of which service income accounts for about 40%, drug, inspection and sanitary materials revenue accounts for the main force, reaching about 29%, 12% and 9%, respectively.
but the capacity of county hospitals is weak.
industry believes that the development of the county market also needs to speed up the primary health care and county hospital service capacity, improve their own technical capacity.
, pharmaceutical companies in the layout of the grass-roots market at the same time, but also need to change their thinking, the use of new marketing models to expand the market.
such as patient-centered service models to attract patients.
this requires pharmaceutical companies to improve their business capacity and the diagnostic capacity of primary doctors, so as to improve the effectiveness of diagnostic programs.
industry believes that academic marketing is still needed in the current pharmaceutical market, but with the overall medical system changes, academic marketing is facing a more professional, compliant rectification.
service ability and return to the essence will replace the traditional marketing methods to become the focus of the development of pharmaceutical companies.